|
#4 Some issues in oncology trials with Progression-free survival (PFS) and Overall Survival (OS) as endpoints
*Gang Chen, Johnson & Johnson *Xiaoping (Janet) Jiang, FDA *Xiaolong Luo, Celgene Keywords:
|
Key Dates
-
April 30 - May 22, 2013
Invited Abstract Submission Open -
June 4, 2013
Online Registration Opens -
August 9 - August 23, 2013
Invited Abstract Editing -
August 23, 2013
Short Course materials due from Instructors -
August 26, 2013
Housing Deadline -
September 9, 2013
Cancellation Deadline and Registration Closes @ 11:59 pm EDT -
September 16 - September 18, 2013
Marriott Wardman Park, Washington, DC
